Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders

Teijeiro, ADjouder, Nabil2019-10-172019-10-172017-02-24Oncoscience. 2017 ;4(1-2):1-2.2331-4737http://hdl.handle.net/20.500.12105/8507engVoRhttp://creativecommons.org/licenses/by-nc-sa/4.0/HCCIL-17ANAD+NASHNicotinamide ribosideNicotinamide riboside or IL-17A signaling blockers to prevent liver disordersAtribución-NoComercial-CompartirIgual 4.0 Internacional2848472541-21-210.18632/oncoscience.338Oncoscienceopen access